Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment

BMC Rheumatology

Per Nived³  Thomas Mandl³  Meliha C. Kapetanovic³  Pierre Geborek⁵  Lillemor Skattum⁷  Tore Saxne⁷ 

[1] , Section of Rheumatology, Lund University, Skå, Sweden;Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, SkåDepartment of Clinical Sciences MalmöDepartment of Infectious Diseases, Central Hospital Kristianstad, Kristianstad, Sweden;Department of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology, Lund University, Lund, Sweden;ne University Hospital, Lund, Sweden;ne University Hospital, Malmö

关键词: Rheumatoid arthritis;    Sjögren’s syndrome;    Pneumococcal vaccination;    Pneumococcal conjugate vaccine;   

DOI  :  10.1186/s41927-018-0019-6

学科分类：内科医学

来源: BioMed Central

【 授权许可】

CC BY